NCT03853733Recruiting
Hypofractionated Palliative Radiotherapy in Patients With Advanced Non-operable Rectal Cancer
Palliative Hypofractionated Radiotherapy in Non-operable Rectal Cancer: A Retrospective Study
Source: ClinicalTrials.gov · Last updated 19 Mar 2026
Brief summary (registry, in English)
Many patients with rectal cancer were not candidates for surgical resection because advanced age, comorbidities, or multiple synchronous metastases. In this scenario only comfort measures or different palliative radiotherapy regimens are applied, from single doses to treatments lasting several weeks. The aim of this prospective study is to describe the preliminary results of our protocol of hypofractionated palliative radiotherapy in patients with non-operable rectal cancer.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 50 (estimated)
- First submitted
- 18 Feb 2019
- Start date
- 1 Oct 2016
- Primary completion date
- 1 Mar 2027
- Lead sponsor
- Consorci Sanitari de Terrassa
- Diseases
- Colorectal cancer
- NCT number
- NCT03853733
What you commit to
- Study type: Observational
- Planned participants: 50
- From 1 Oct 2016 to the primary completion date, 1 Mar 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients treated with concurrent chemotherapy
- Patients candidates for surgical resection after radiotherapy
Other illness
- Patients with a non rectum or sigma colo-rectal cancer.
Age
- Patients with \<18 years old.
Who the study is looking for
- Patients with rectal or sigmoidal cancer who were not candidates for surgical resection because advanced age, comorbidities, or multiple synchronous metastases at the time of diagnosis
- Patients with = or \> 18 years old
- Patients treated with a radiotherapy dose of 39Gy in 13 fractions of 3 Gy
Age in the registry: 18 years to - · Sex: All
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Consorci Sanitari de Terrassa Coordinator of this site? Confirm its status | Terrassa | Spain | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.